NCT04722653View on ClinicalTrials.gov

A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions
Non-alcoholic Steatohepatitis
Interventions
DRUG

NNC0194-0499

1 single dose administered subcutaneously (s.c. - under the skin)

DRUG

Placebo (NNC0194-0499 )

1 single dose administered subcutaneously (s.c. - under the skin).

Trial Locations (1)

130-0004

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT04722653 - A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men | Biotech Hunter | Biotech Hunter